reglab/housing_qa huggingface dataset:
UT Code § 58-17b-805 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 8 - Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy|Section 805 - Dispensing medical practitioner -- Cancer drug treatment regimen.

 Effective 5/14/2019  58-17b-805. Dispensing medical practitioner -- Cancer drug treatment regimen.    (1) For purposes of this section:   (a) "Cancer drug treatment regimen" means a prescription drug used to treat cancer, manage its symptoms, or provide continuity of care for a cancer patient.     (b) "Cancer drug treatment regimen" includes:   (i) a chemotherapy drug administered intravenously, orally, rectally, or by dermal methods; and     (ii) a drug used to support cancer treatment, including a drug used to treat, alleviate, or minimize physical and psychological symptoms or pain, to improve patient tolerance of cancer treatments, or to prepare a patient for a subsequent course of therapy.       (c) "Cancer drug treatment regimen" does not mean a drug listed under federal law as a Schedule I, II, or III drug.       (2) An individual may be licensed as a dispensing medical practitioner with a scope of practice that permits the dispensing medical practitioner to prescribe and dispense a cancer drug treatment regimen if the individual:   (a) is licensed as described in Subsections 58-17b-102(23)(a)(i) and (ii); and     (b) is certified or eligible to be certified by:   (i) the American Board of Internal Medicine in medical oncology; or     (ii) the American Board of Urology.         (3) A dispensing medical practitioner authorized to prescribe and dispense a cancer drug treatment regimen under this section may prescribe and dispense a cancer drug treatment regimen:   (a) to the practitioner's patient who is currently undergoing chemotherapy in an outpatient clinic setting; and     (b) if the practitioner determines that providing the cancer drug treatment regimen to the patient in the outpatient clinic setting is in the best interest of the patient or provides better access to care for the patient.      Amended by Chapter 343, 2019 General Session
UT Code § 58-17b-806 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 8 - Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy|Section 806 - Enforcement of dispensing medical practitioner and dispensing medical practitioner clinic pharmacy compliance with Pharmacy Practice Act.

 Effective 7/1/2014  58-17b-806. Enforcement of dispensing medical practitioner and dispensing medical practitioner clinic pharmacy compliance with Pharmacy Practice Act.    (1)   (a) The division shall consult with the dispensing medical practitioner's appropriate licensing board as designated in Subsection 58-17b-102(23)(a) regarding a violation of this chapter; and     (b) the Pharmacy Board shall, if requested by the licensing board of the dispensing medical practitioner, assist the licensing board for the dispensing medical practitioner with reviewing the violations of the provisions of this chapter.       (2) The division may take appropriate action against a dispensing medical practitioner, in accordance with this chapter, if the licensing board designated in Subsection 58-17b-102(23)(a) recommends to the division that action be taken under this chapter.     (3) The division, in consultation with the board is the primary enforcer under this chapter for a dispensing medical practitioner clinic pharmacy licensed under Section 58-17b-804.    Enacted by Chapter 72, 2014 General Session
UT Code § 58-17b-901 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 9 - Charitable Prescription Drug Recycling Act|Section 901 - Title.

 Effective 5/10/2016  58-17b-901. Title.  This part is known as the "Charitable Prescription Drug Recycling Act." Enacted by Chapter 405, 2016 General Session
UT Code § 58-17b-903 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 9 - Charitable Prescription Drug Recycling Act|Section 903 - Charitable Prescription Drug Recycling Program -- Creation -- Requirements.

 Effective 5/5/2021  58-17b-903. Charitable Prescription Drug Recycling Program -- Creation -- Requirements.    (1) There is created the Charitable Prescription Drug Recycling Program.     (2) The division, in consultation with the board, shall:   (a) implement the program, on a statewide basis, to permit:   (i) an individual or an eligible donor to transfer an eligible prescription drug to an eligible pharmacy for dispensing to a medically indigent individual; and     (ii) an individual to transfer an eligible prescription drug to a physician's office:   (A) that is an eligible donor; and     (B) for transfer to an eligible pharmacy for dispensing to a medically indigent individual;         (b) in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, make rules necessary to implement the program; and     (c) provide technical assistance to entities that desire to participate in the program.      Amended by Chapter 397, 2021 General Session
UT Code § 58-17b-904 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 9 - Charitable Prescription Drug Recycling Act|Section 904 - Criteria for eligible prescription drugs.

 Effective 5/10/2016  58-17b-904. Criteria for eligible prescription drugs.  An eligible pharmacy may not accept or dispense an unused prescription drug under the program unless the unused prescription drug:  (1)   (a) is in a unit pack or the manufacturer's sealed container; or     (b) is an injectable medication;       (2)   (a) is unopened; or     (b) is a cancer drug packaged in an unopened single-unit dose that has been removed from a multi-dose package;       (3) is accepted and dispensed by the eligible pharmacy before:   (a) a beyond use date that appears on the label;     (b) the expiration date recommended by the manufacturer; or     (c) a date, established by division rule for a specific prescription drug, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, that is later than the date in Subsection (3)(a) or (3)(b);       (4)   (a) is not adulterated or mislabeled; and     (b) the pharmacist or licensed pharmacist technician accepting or dispensing the prescription drug does not have reason to believe that the prescription drug is adulterated or mislabeled.      Enacted by Chapter 405, 2016 General Session
UT Code § 58-17b-905 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 9 - Charitable Prescription Drug Recycling Act|Section 905 - Participation in program -- Requirements -- Fees.

 Effective 5/5/2021  58-17b-905. Participation in program -- Requirements -- Fees.    (1) An eligible donor, an individual, or an eligible pharmacy may participate in the program.     (2) An eligible pharmacy:   (a) shall comply with all applicable federal and state laws related to the storage and distribution of a prescription drug;     (b) shall comply with all applicable federal and state laws related to the acceptance and transfer of a prescription drug, including 21 U.S.C. Chapter 9, Subchapter V, Part H, Pharmaceutical Distribution Supply Chain;     (c) shall, before accepting or dispensing a prescription drug under the program, inspect each prescription drug to determine whether the prescription drug is an eligible prescription drug;     (d) may dispense an eligible prescription drug to a medically indigent individual who:   (i) is located in the state when the drug is dispensed; and     (ii) has a prescription issued by a practitioner;       (e) may charge a handling fee, adopted by the division under Section 63J-1-504; and     (f) may not accept, transfer, or dispense a prescription drug in violation of the federal Food, Drug, and Cosmetic Act, 21 U.S.C. Sec. 301 et seq.      Amended by Chapter 397, 2021 General Session
UT Code § 58-17b-906 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 9 - Charitable Prescription Drug Recycling Act|Section 906 - Liability of participating organizations and manufacturers.

 Effective 5/10/2016  58-17b-906. Liability of participating organizations and manufacturers.  In the absence of bad faith or gross negligence, a person is not criminally or civilly liable for injury, death, or loss of property based solely on the fact that the person manufactured, provided, donated, accepted, or dispensed an eligible prescription drug under this part.  Enacted by Chapter 405, 2016 General Session
UT Code § 58-17b-907 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 9 - Charitable Prescription Drug Recycling Act|Section 907 - Rules made by the division.

 Effective 5/5/2021  58-17b-907. Rules made by the division.  The rules made by the division under Subsection 58-17b-903(2)(b) shall include:  (1) registration requirements to establish the eligibility of a pharmacy to participate in the program;     (2) a formulary that includes all eligible prescription drugs approved by the federal Food and Drug Administration;     (3) standards and procedures for:   (a) verifying whether a pharmacy or pharmacist participating in the program is licensed and in good standing with the board;     (b) handling of an eligible prescription drug transferred in accordance with Subsection 58-17b-903(2) to an eligible pharmacy or a physician's office, including:   (i) acceptance;     (ii) identification, including redundant criteria for verification;     (iii) documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history, and statements;     (iv) safe storage;     (v) security;     (vi) inspection;     (vii) transfer; and     (viii) dispensing;       (c) a pharmacist, pharmacy intern, or licensed pharmacy technician:   (i) working in or consulting with a participating eligible donor; or     (ii) assisting an individual donating the eligible prescription drug;       (d) disposition of a donated prescription drug that is a controlled substance;     (e) record keeping regarding:   (i) the individual or eligible donor that transferred an eligible prescription drug under Subsection 58-17b-903(2)(a);     (ii) the identification and evaluation of a donated prescription drug by a pharmacist or licensed pharmacy technician; and     (iii) the dispensing or disposition of a prescription drug;       (f) determining the status of a medically indigent individual;     (g) labeling requirements to:   (i) ensure compliance with patient privacy laws relating to:   (A) an individual who receives an eligible prescription drug; and     (B) patient information that may appear on a donated prescription drug;       (ii) clearly identify an eligible prescription drug dispensed under the program; and     (iii) communicate necessary information regarding the manufacturer's recommended expiration date or the beyond use date; and       (h) ensuring compliance with the requirements of this part;       (4) a process for seeking input from:   (a) the Department of Health, created in Section 26-1-4, to establish program standards and procedures for assisted living facilities and nursing care facilities; and     (b) the Division of Substance Abuse and Mental Health, created in Section 62A-15-103, to establish program standards and procedures for mental health and substance abuse clients; and       (5) the creation of a special training program that a pharmacist and a licensed pharmacy technician at an eligible pharmacy must complete before participating in the program.    Amended by Chapter 397, 2021 General Session
UT Code § 58-17b-1001 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 10 - Epinephrine Auto-injector and Stock Albuterol Act|Section 1001 - Title.

 Effective 7/1/2020  58-17b-1001. Title.  This part is known as the "Epinephrine Auto-Injector and Stock Albuterol Act." Enacted by Chapter 372, 2020 General Session
UT Code § 58-17b-1002 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 10 - Epinephrine Auto-injector and Stock Albuterol Act|Section 1002 - Definitions.

 Effective 7/1/2020  58-17b-1002. Definitions.  As used in this part:  (1) "Epinephrine auto-injector" means the same as that term is defined in Section 26-41-102.     (2) "Local health department" means the same as that term is defined in Section 26A-1-102.     (3) "Physician" means the same as that term is defined in Section 58-67-102.     (4) "Qualified adult" means the same as that term is defined in Section 26-41-102.     (5) "Qualified epinephrine auto-injector entity" means the same as that term is defined in Section 26-41-102.     (6) "Qualified stock albuterol entity" means the same as that term is defined in Section 26-41-102.     (7) "Stock albuterol" means the same as that term is defined in Section 26-41-102.    Enacted by Chapter 372, 2020 General Session
UT Code § 58-17b-1003 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 10 - Epinephrine Auto-injector and Stock Albuterol Act|Section 1003 - Voluntary participation.

 Effective 7/1/2020  58-17b-1003. Voluntary participation.  This part does not create a duty or standard of care for a person to prescribe or dispense an epinephrine auto-injector or stock albuterol. Enacted by Chapter 372, 2020 General Session
UT Code § 58-17b-1004 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 10 - Epinephrine Auto-injector and Stock Albuterol Act|Section 1004 - Authorization to dispense an epinephrine auto-injector and stock albuterol pursuant to a standing order.

 Effective 7/1/2020  58-17b-1004. Authorization to dispense an epinephrine auto-injector and stock albuterol pursuant to a standing order.    (1) Notwithstanding any other provision of this chapter, a pharmacist or pharmacy intern may dispense an epinephrine auto-injector:   (a)   (i) to a qualified adult for use in accordance with Title 26, Chapter 41, Emergency Response for Life-threatening Conditions; or     (ii) to a qualified epinephrine auto-injector entity for use in accordance with Title 26, Chapter 41, Emergency Response for Life-threatening Conditions;       (b) pursuant to a standing prescription drug order made in accordance with Section 58-17b-1005;     (c) without any other prescription drug order from a person licensed to prescribe an epinephrine auto-injector; and     (d) in accordance with the dispensing guidelines in Section 58-17b-1006.       (2) Notwithstanding any other provision of this chapter, a pharmacist or pharmacy intern may dispense stock albuterol:   (a)   (i) to a qualified adult for use in accordance with Title 26, Chapter 41, Emergency Response for Life-threatening Conditions; or     (ii) to a qualified stock albuterol entity for use in accordance with Title 26, Chapter 41, Emergency Response for Life-threatening Conditions;       (b) pursuant to a standing prescription drug order made in accordance with Section 58-17b-1005;     (c) without any other prescription drug order from a person licensed to prescribe stock albuterol; and     (d) in accordance with the dispensing guidelines in Section 58-17b-1006.      Amended by Chapter 4, 2020 Special Session 5
UT Code § 58-17b-1005 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 10 - Epinephrine Auto-injector and Stock Albuterol Act|Section 1005 - Standing prescription drug orders for epinephrine auto-injectors and stock albuterol.

 Effective 7/1/2020  58-17b-1005. Standing prescription drug orders for epinephrine auto-injectors and stock albuterol.    (1) A physician acting in the physician's capacity as an employee of the Department of Health or as a medical director of a local health department may issue a standing prescription drug order authorizing the dispensing of an epinephrine auto-injector under Section 58-17b-1004 in accordance with a protocol that:   (a) requires the physician to specify the persons, by professional license number, authorized to dispense the epinephrine auto-injector;     (b) requires the physician to review at least annually the dispensing practices of those authorized by the physician to dispense the epinephrine auto-injector;     (c) requires those authorized by the physician to dispense the epinephrine auto-injector to make and retain a record of each dispensing, including:   (i) the name of the qualified adult or qualified epinephrine auto-injector entity to whom the epinephrine auto-injector is dispensed;     (ii) a description of the epinephrine auto-injector dispensed; and     (iii) other relevant information; and       (d) is approved by the division by administrative rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, in collaboration with the Physicians Licensing Board created in Section 58-67-201 and the Board of Pharmacy.       (2) A physician acting in the physician's capacity as an employee of the Department of Health or as a medical director of a local health department may issue a standing prescription drug order authorizing the dispensing of stock albuterol under Section 58-17b-1004 in accordance with a protocol that:   (a) requires the physician to specify the persons, by professional license number, authorized to dispense the stock albuterol;     (b) requires the physician to review at least annually the dispensing practices of those authorized by the physician to dispense the stock albuterol;     (c) requires those authorized by the physician to dispense the stock albuterol to make and retain a record of each dispensing, including:   (i) the name of the qualified adult or qualified stock albuterol entity to whom the stock albuterol is dispensed;     (ii) a description of the stock albuterol dispensed; and     (iii) other relevant information; and       (d) is approved by the division by administrative rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, in collaboration with the Physicians Licensing Board created in Section 58-67-201 and the board.      Amended by Chapter 4, 2020 Special Session 5
UT Code § 58-17b-1006 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 10 - Epinephrine Auto-injector and Stock Albuterol Act|Section 1006 - Guidelines for dispensing an epinephrine auto-injector and stock albuterol.

 Effective 7/1/2020  58-17b-1006. Guidelines for dispensing an epinephrine auto-injector and stock albuterol.    (1) A pharmacist or pharmacy intern who dispenses an epinephrine auto-injector under this part shall, at a minimum, provide patient counseling to the qualified adult or qualified epinephrine auto-injector entity to whom the epinephrine auto-injector is dispensed regarding:   (a) the appropriate administration and storage of the epinephrine auto-injector;     (b) potential side effects and risks of the epinephrine auto-injector; and     (c) when to seek emergency medical attention.       (2) A pharmacist or pharmacy intern who dispenses stock albuterol under this part shall, at a minimum, provide patient counseling to the qualified adult or qualified stock albuterol entity to whom the stock albuterol is dispensed regarding:   (a) the appropriate administration and storage of the stock albuterol;     (b) potential side effects and risks of the stock albuterol; and     (c) when to seek emergency medical attention.      Enacted by Chapter 372, 2020 General Session
UT Code § 58-17b-1007 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 17b - Pharmacy Practice Act|Part 10 - Epinephrine Auto-injector and Stock Albuterol Act|Section 1007 - Limited civil liability.

 Effective 7/1/2020  58-17b-1007. Limited civil liability.    (1) A physician who issues a standing prescription drug order in accordance with Subsection 58-17b-1005(1) is not liable for any civil damages for acts or omissions resulting from the dispensing of an epinephrine auto-injector under this part.     (2) A physician who issues a standing prescription drug order in accordance with Subsection 58-17b-1005(2) is not liable for any civil damages for acts or omissions resulting from the dispensing of stock albuterol under this part.    Enacted by Chapter 372, 2020 General Session
UT Code § 58-20b-101 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 20b - Environmental Health Scientist Act|Part 1 - General Provisions|Section 101 - Title.

 Affected by 63I-1-258 on 7/1/2028  Effective 12/3/2018  58-20b-101. Title.  This chapter is known as the "Environmental Health Scientist Act." Enacted by Chapter 1, 2018 Special Session 3
UT Code § 58-20b-102 (2021)
2021 Utah Code|Title 58 - Occupations and Professions|Chapter 20b - Environmental Health Scientist Act|Part 1 - General Provisions|Section 102 - Definitions.

 Affected by 63I-1-258 on 7/1/2028  Effective 12/3/2018  58-20b-102. Definitions.  In addition to the definitions in Section 58-1-102, as used in this chapter:  (1) "Accredited program" means a degree-offering program from:   (a) an institution, college, or university that is accredited by the Department of Education or the Council for Higher Education Accreditation; or     (b) a non-accredited institution, college, or university that offers education equivalent to Department of Education-accredited programs, as determined by a third party selected by the board.       (2) "Board" means the Environmental Health Scientist Board created in Section 58-20b-201.     (3) "General supervision" means the supervising environmental health scientist is available for immediate voice communication with the person he or she is supervising.     (4) "Practice of environmental health science" means:   (a) the enforcement of, the issuance of permits required by, or the inspection for the purpose of enforcing state and local public health laws in the following areas:   (i) air quality;     (ii) food quality;     (iii) solid, hazardous, and toxic substances disposal;     (iv) consumer product safety;     (v) housing;     (vi) noise control;     (vii) radiation protection;     (viii) water quality;     (ix) vector control;     (x) drinking water quality;     (xi) milk sanitation;     (xii) rabies control;     (xiii) public health nuisances;     (xiv) indoor clean air regulations;     (xv) institutional and residential sanitation; or     (xvi) recreational facilities sanitation; or       (b) representing oneself in any manner as, or using the titles "environmental health scientist," "environmental health scientist-in-training," or "registered sanitarian."       (5) "Unlawful conduct" means the same as that term is defined in Section 58-1-501.     (6) "Unprofessional conduct" means the same as that term is defined in Sections 58-1-501 and 58-20b-501 and as may be further defined by division rule.    Enacted by Chapter 1, 2018 Special Session 3